Paperpal Prime Logo

In Vivo : Impact Factor & More

eISSN: 1791-7549pISSN: 0258-851X

Key Metrics

CiteScore
3.1
Impact Factor
< 5
SJR
Q4Pharmacology
SNIP
0.84
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on In Vivo

In Vivo Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher INT INST ANTICANCER RESEARCH
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1987
Website URLVisit website
View less

Planning to publish in In Vivo ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in In Vivo

Impact of Intravenous Immunoglobulin on Neuroinflammation Markers in Patients With Electrical Status Epilepticus During Slow Sleep
  • 3 Jul 2026
  • In Vivo
A Novel Snore Recording Application Demonstrating High Correlation With Two-channel Portable Monitoring for Diagnosing Sleep Apnea Syndrome
  • 3 Jul 2026
  • In Vivo
Identification of Differentially Expressed Genes in Nonfunctioning Pituitary Adenoma by Transcriptome Analysis
  • 30 Jun 2026
  • In Vivo
Combined All-trans Retinoic Acid and Rosiglitazone Alleviates Scleroderma Fibrosis by Suppressing the STAT3/Th17 Axis
  • 30 Jun 2026
  • In Vivo
Adverse Event Profiling and Comparative Analysis of HER2-targeting Antibody\u2013drug Conjugates Using Pharmacovigilance Databases
  • 30 Jun 2026
  • In Vivo
Real-world Implementation of Adjuvant Pembrolizumab for High-risk Clear-cell Renal Cell Carcinoma After Surgery
  • 30 Jun 2026
  • In Vivo
Impact of Intravenous Immunoglobulin on Neuroinflammation Markers in Patients With Electrical Status Epilepticus During Slow Sleep
  • 3 Jul 2026
  • In Vivo
A Novel Snore Recording Application Demonstrating High Correlation With Two-channel Portable Monitoring for Diagnosing Sleep Apnea Syndrome
  • 3 Jul 2026
  • In Vivo
Identification of Differentially Expressed Genes in Nonfunctioning Pituitary Adenoma by Transcriptome Analysis
  • 30 Jun 2026
  • In Vivo
Combined All-trans Retinoic Acid and Rosiglitazone Alleviates Scleroderma Fibrosis by Suppressing the STAT3/Th17 Axis
  • 30 Jun 2026
  • In Vivo
Adverse Event Profiling and Comparative Analysis of HER2-targeting Antibody\u2013drug Conjugates Using Pharmacovigilance Databases
  • 30 Jun 2026
  • In Vivo
Real-world Implementation of Adjuvant Pembrolizumab for High-risk Clear-cell Renal Cell Carcinoma After Surgery
  • 30 Jun 2026
  • In Vivo

FAQs on In Vivo